SINTX Technologies Hits New 52-Week Low at $1.85 Amid Ongoing Struggles

SINTX Technologies, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 1.85 as of June 25, 2026. This significant decline reflects a challenging year for the company, which has seen its stock price plummet by 59.12% over the past year, contrasting sharply with the S&P 500's performance of 20.77% during the same period. The company's financial metrics indicate ongoing difficulties, with a negative return on equity of -349.61% and a debt-to-equity ratio of -1.28. SINTX has reported losses for five consecutive quarters, with net sales declining by 26.45% to USD 0.67 million. Additionally, the company's return on capital employed (ROCE) has reached a low of -311.41%, and its inventory turnover ratio stands at just 1.12 times. Institutional investor participation has also waned, with a decrease of 1.89% in their stakes, now collectively holding 11.43% of the company. This trend, coupled with the stock's underperformance relative to broader market indices, underscores the challenges facing SINTX Technologies as it navigates a difficult financial landscape.